This recent “Washington Post” article is about the “gut-first” hypothesis of Parkinson’s disease (PD) — the idea that a high percentage of PD cases start in the gut and that abnormal protein spreads from the gut to the brain. Evidence is that constipation can begin more than a decade before motor symptoms of PD. And abnormal proteins can be found almost the whole length of the digestive tract.
… Full Story>
On March 20, 2026, the U.S. Food and Drug Administration (FDA) issued a safety warning that requires products containing carbidopa/levodopa to carry new labeling which warns about the potential for Vitamin B6 (pyridoxine) deficiency. The warning guides physicians and other health care professionals to test for baseline vitamin B6 levels (with a blood test) prior to starting patients on treatment with carbidopa/levodopa therapies and periodically while on treatment and to supplement with vitamin B6 as necessary. Of note – it is important that patients do not take vitamin B6 on their own without monitoring blood levels, since vitamin B6 levels that are too high can be dangerous as well.
… Full Story>
Register now for “Employment and Parkinson’s: Rights and Protections,” which will be of particular interest to the Young Onset Parkinson’s Disease (YOPD) community. This is the second installment of a three-part virtual lecture series featuring expert speakers and people with Parkinson’s, who address both practical and emotional challenges of YOPD.
… Full Story>
En febrero de 2026, la Parkinson’s Foundation presentó un webinar en español con la Dra. Natalie Díaz, neuróloga y especialista en trastornos del movimiento en Pacific Neuroscience Institute en Torrance, California, que también ha trabajado como investigadora en ensayos clínicos. La Dra. Díaz ofreció un panorama práctico de los tratamientos más recientes para la EP: nuevos medicamentos orales, dos terapias de infusión subcutánea y un tercer fármaco en espera de aprobación, además de avances en la estimulación cerebral profunda y el ultrasonido focalizado.
… Full Story>
We stand in solidarity with the Parkinson’s community to raise awareness and advance research toward a cure for Parkinson’s disease.
… Full Story>